Covington Steers AstraZeneca's $1.8B Bid For US Biotech Biz
British-Swedish pharmaceutical giant AstraZeneca, led by Covington & Burling LLP, said on Monday that it will buy U.S. biotechnology company CinCor Pharma for up to $1.8 billion to strengthen its drug...To view the full article, register now.
Already a subscriber? Click here to view full article